Related Experiment Video
Updated: Apr 16, 2026
11:32
Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.8K
Improving outcomes from community-acquired pneumonia
Grant Waterer1, Lesley Bennett
1aUniversity of Western Australia, Perth, WA, Australia bNorthwestern University, Chicago, Illinois, USA cRoyal Perth Hospital, Perth, Western Australia, Australia.
Current Opinion in Pulmonary Medicine
|March 13, 2015
Summary
Physicians should compare community-acquired pneumonia (CAP) outcomes to improve patient care. A bundle of care, including rapid antibiotics and early mobilization, is recommended for better results.
Area of Science:
- Healthcare quality improvement
- Clinical outcomes research
- Infectious disease management
Background:
- Public reporting of clinical outcomes is increasing.
- Quality of care for community-acquired pneumonia (CAP) requires focused attention.
- Individual clinician performance metrics are becoming more prevalent.
Purpose of the Study:
- To review the quality of care for CAP patients.
- To identify optimal outcome measures and data requirements.
- To recommend evidence-based care bundles for improved CAP outcomes.
Main Methods:
- Literature review of current evidence on CAP quality of care.
- Analysis of outcome reporting and data quality in pneumonia care.
- Synthesis of recommended interventions for favorable patient outcomes.
Main Results:
- Pneumonia outcomes, especially mortality, have improved over the last decade.
- Current quality targets for CAP may be oversimplified.
- A comprehensive bundle of care is necessary for optimal outcomes, similar to sepsis management.
- Data quality for outcome comparison needs substantial improvement.
Conclusions:
- Physicians must actively compare outcomes against peers, not rely on historical data.
- A care bundle including rapid antibiotic administration, combination therapy with macrolides, and early mobilization is a recommended starting point.
- Improving data quality is crucial for accurate outcome assessment and benchmarking.
Related Concept Videos
01:28Pneumonia IV: Management
1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
01:30Pneumonia V: Nursing management and Prevention
4.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
01:30Pneumonia III: Complications and Assessment
1.3K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.3K
01:30Pneumonia I: Introduction
1.4K
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.4K
01:14Atypical Pneumonia
67
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
67
01:29Pneumonia II: Pathophysiology
4.4K
The pathophysiology of pneumonia involves the following steps:
4.4K